Blood test distinguishes neuroendocrine subtype of advanced prostate cancer

Дата публикации: 10-01-2024 17:02:21

Researchers have developed a blood test that can reliably detect neuroendocrine prostate cancer and differentiate it from castration-resistant prostate cancer-adenocarcinoma (CRPC-adeno).

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	New urine-based test detects high-grade prostate cancer, helping men avoid unnecessary biopsies	5	7	18-04-2024
2	New blood test for noncoding RNA significantly improves cancer detection	5	7	31-08-2023
3	MRI scans improve prostate cancer diagnosis in screening trial	2	7	22-08-2023
4	Innovative model provides valuable insights into prostate cancer spread	7	8	23-09-2024
5	MRI-first strategy for prostate cancer detection proves to be safe, study finds	5	7	19-12-2024
6	New blood test shows superior sensitivity in detecting HPV-associated head and neck cancers	7	8	20-05-2025
7	Precision therapy for metastatic prostate cancer improves survival	2	7	20-08-2024
8	Study helps predict how long it will take for testosterone to return to normal after prostate cancer treatment	5	7	25-09-2024
9	Doctors just found a way to slow one of the deadliest prostate cancers	7	8	22-10-2025
10	Study finds 1 in 12 patients labeled as having 'benign' results actually had high-risk prostate cancer	0	8	09-07-2024

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 5. Информативность: 7. Источник: www.sciencedaily.com.